BILLEV PHARMA EAST

NEWS AND EVENTS

Ukraine’s Regulatory Reforms from May 2024

Abolition of GMP Simplifications Effective from April 17, 2024, Ukraine has abolished the temporary ...

16.05.2024

Over the past decade, supply chains within the pharmaceutical industry have become increasingly comp...

11.04.2024

The presence of nitrosamine impurities in medicinal products has raised safety concerns regarding th...

25.03.2024

EudraVigilance is the European data-processing network and database management system for the exchan...

14.03.2024

The integration of Artificial Intelligence (AI) into medical devices is revolutionizing healthcare, ...

08.03.2024

Billev Pharma East experts can act as your outsourced PRRC, helping your Company comply with EU regu...

28.02.2024

At the end of January 2024 Swissmedic updated its Q&A document Update of the requirements for de...

27.02.2024

In order to combat critical medicines shortages The European Medicines Agency (EMA) together with th...

23.02.2024

Billev Pharma East is proud to announce that we have become a member of the elite SBC club of the mo...

05.02.2024

The regulation of a combination products (the combination of a medicinal product and a medical devic...

22.01.2024

On December 2023 Guidance on Article 15 of the medical device regulation (MDR) and in vitro diagnost...

10.01.2024

The Medicines and Healthcare products Regulatory Agency (MHRA) signed a Grant Agreement with the Con...

09.01.2024

In December 2023, Medical Device Coordination Group (MDCG) issued a revised document, MDCG 2021-27 R...

08.01.2024

EMA, the European Commission, and the Heads of Medicines Agencies (HMA) have phased out the special ...

14.12.2023

Regulation (EU) 2017/745 – also known as the Medical Devices Regulation (MDR) was adopted on May 2...

05.12.2023

Europe's healthcare systems confront formidable challenges, imperilling access, affordability, and q...

30.11.2023

1 14